DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DUTOGLIPTIN

« Back to Dashboard

Clinical Trials for Dutogliptin

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00690638	Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus	Completed	Forest Laboratories	Phase 3	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T as Monotherapy in Subjects with Type 2 Diabetes Mellitus
NCT00690638	Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus	Completed	Phenomix	Phase 3	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T as Monotherapy in Subjects with Type 2 Diabetes Mellitus
NCT00850239	Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin	Terminated	Forest Laboratories	Phase 3	The purpose of this study is to demonstrate the efficacy of dutogliptin over 26 weeks (as evidenced by placebo-corrected changes in HbA1c relative to baseline), to demonstrate safety and tolerability of dutogliptin, and to demonstrate changes in fasting plasma glucose over 26 weeks.
NCT00850239	Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin	Terminated	Phenomix	Phase 3	The purpose of this study is to demonstrate the efficacy of dutogliptin over 26 weeks (as evidenced by placebo-corrected changes in HbA1c relative to baseline), to demonstrate safety and tolerability of dutogliptin, and to demonstrate changes in fasting plasma glucose over 26 weeks.

Clinical Trial Conditions for Dutogliptin

Condition Name

Condition Name for
Intervention	Trials
Type 2 Diabetes Mellitus	6
Diabetes Mellitus, Type II	2
Diabetes Mellitus, Type 2	1
Acute Myocardial Ischemia	1

Condition MeSH

Condition MeSH for
Intervention	Trials
Diabetes Mellitus, Type 2	9
Diabetes Mellitus	9
Renal Insufficiency	1
ST Elevation Myocardial Infarction	1

Clinical Trial Locations for Dutogliptin

Trials by Country

Trials by Country for
Location	Trials
United States	180
India	40
Argentina	9
Peru	9
Romania	6

Trials by US State

Trials by US State for
Location	Trials
California	10
Texas	9
Florida	9
North Carolina	8
Virginia	7

Clinical Trial Progress for Dutogliptin

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 3	8
Phase 2	2

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase	Trials
Terminated	8
Completed	1
Recruiting	1

Clinical Trial Sponsors for Dutogliptin

Sponsor Name

Sponsor Name for
Sponsor	Trials
Phenomix	9
Forest Laboratories	8
Recardio, Inc.	1

Sponsor Type

Sponsor Type for
Sponsor	Trials
Industry	18